Inhalational induction: A safe anaesthetic management in a patient with crouzon syndrome
, , , and
Dec 29, 2022
About this article
Article Category: Case-Report
Published Online: Dec 29, 2022
Page range: 61 - 62
DOI: https://doi.org/10.2478/rjaic-2021-0010
Keywords
© 2021 Sudeep Mohapatra et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Crouzon syndrome is a rare genetic disorder involving craniofacial skeleton development. It’s characterized by a triad of cranial deformities: premature craniosynostosis, facial anomalies (mid-facial hypoplasia), and exophthalmia. The anaesthetic management challenges include the presence of a difficult airway, history of obstructive sleep apnea, congenital cardiac disorders, hypothermia, blood loss, and venous air embolism. We present the case of an infant with Crouzon syndrome who was scheduled for a ventriculoperitoneal shunt placement managed with inhalational induction.